Novo Nordisk’s latest investigational weight loss treatment, CagriSema, has failed to achieve its primary endpoint of demonstrating non-inferiority when compared…
Read More
Identification of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment
The landscape of regenerative medicine and orthopedics has been significantly advanced by the identification of Family with Sequence Similarity 102…
Read More
HKUMed Researchers Identify Piezo1 Protein as Molecular Exercise Sensor Offering New Hope for Osteoporosis Treatment and Bone Health Maintenance
Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…
Read More
First-of-its-Kind Implant Promises Dramatic Improvement for Severe Tissue Loss Treatment
An international research consortium, spearheaded by the renowned Levenberg Laboratory at the Technion-Israel Institute of Technology, has unveiled a groundbreaking,…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
The landscape of mental health treatment witnessed a significant development on February 17, 2026, as Compass Pathways, a leading mental…
Read More
Unlocking the Mechanism of Lecanemab: VIB-KU Leuven Researchers Identify Fc Fragment as Essential for Microglial Activation in Alzheimer’s Treatment
Researchers from the VIB-KU Leuven Center for Brain & Disease Research have published a seminal study in the journal Nature…
Read More
Novo Nordisk’s new weight loss treatment inferior to Lilly’s tirzepatide
Novo Nordisk, a global leader in diabetes and obesity care, announced on Monday that its investigational weight loss treatment, CagriSema,…
Read More
Researchers Create First Fully Human 3D Bone Marrow Model to Advance Cancer Treatment and Reduce Animal Testing
In a landmark development for regenerative medicine and oncology, scientists at the University of Basel and University Hospital Basel have…
Read More
